Cardinal Health Specialty Solutions

Dublin, Ohio 43017

0 studies enrolling now · 2 studies all time

What they study most

Myelofibrosis, Squamous Non-small Cell Lung Cancer

Studies at this site

• A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib — Completed
• A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung — Completed